Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study

Ergun, Yakup; Ozdemir, Nuriye; Toptas, Serife; Kurtipek, Alican; Eren, Tulay; Yazic, Ozan; ŞENDUR, MEHMET; Akinci, Bulent; Ucar, Gokhan; Oksuzoglu, Berna; Uncu, Dogan

Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study

Atıf İçin Kopyala

Ergun Y., Ozdemir N. Y. , Toptas S., Kurtipek A., Eren T., Yazic O., ...Daha Fazla

JOURNAL OF BUON, cilt.24, sa.4, ss.1719-1726, 2019 (SCI İndekslerine Giren Dergi)

Cilt numarası: 24 Konu: 4
Basım Tarihi: 2019
Dergi Adı: JOURNAL OF BUON
Sayfa Sayıları: ss.1719-1726

Özet

Purpose: Tyrosine kinase inhibitors (TKIs) are frequently used drugs in oncology practice. Although oral administration is an advantage, long-term use increases potential drug-drug interaction risk. The purpose of this study was to assess the prevalence of potential TKI-drug interaction (PTDI) in patients who used TKIs and increase awareness of this subject.